Clinica Baviera (XMAD:CBAV) Debt-to-Asset : 0.04 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:CBAV Clinica Baviera SA XMAD:CBAV
100 GF Score
Price €58.80
GF Value €44.45
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clinica Baviera Debt-to-Asset?

Clinica Baviera XMAD:CBAV +0.68% 100 Debt-to-Asset is 0.04 as of Jun. 2026. GuruFocus rates XMAD:CBAV with a GF Score™ of 100/100 and a GF Value™ of €44.45 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Clinica Baviera's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €2.6 Mil. Clinica Baviera's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €7.3 Mil. Clinica Baviera's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was €254.8 Mil. Clinica Baviera's debt to asset for the quarter that ended in Jun. 2026 was 0.04.

Clinica Baviera  (XMAD:CBAV) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Clinica Baviera Debt-to-Asset Related Terms

Clinica Baviera Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Clinica Baviera's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera Debt-to-Asset Chart

Clinica Baviera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.32 0.27 0.30 0.29

Clinica Baviera Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.29 0.29 0.26 0.04

XMAD:CBAV vs TMO, DHR, IDXX: Debt-to-Asset Comparison

For the Diagnostics & Research subindustry, Clinica Baviera's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinica Baviera Debt-to-Asset vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Debt-to-Asset falls into.


XMAD:CBAV
100GF Score
Clinica Baviera SA XMAD:CBAV
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinica Baviera Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Clinica Baviera's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(13.14 + 57.48) / 247.508
=0.29

Clinica Baviera's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.575 + 7.321) / 254.841
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.04 mean?
Clinica Baviera (XMAD:CBAV) has a Debt-to-Asset of 0.04 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Clinica Baviera and its competitors.
Is Clinica Baviera's Debt-to-Asset too high?
Clinica Baviera's current Debt-to-Asset is 0.04. Overall, Clinica Baviera has a GF Score™ of 100/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's Debt-to-Asset compare to TMO and DHR?
Clinica Baviera's Debt-to-Asset of 0.04 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Diagnostics & Research company?
A good Debt-to-Asset depends on the Medical Diagnostics & Research industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current Debt-to-Asset is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €44.45, compared to a current price of €58.80 — trading 32.3% above its estimated fair value. The current Debt-to-Asset is 0.04. Clinica Baviera's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current Debt-to-Asset is 0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €58.80 is trading 32.3% above its estimated GF Value™ of €44.45. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • Debt-to-Asset: 0.04
  • GF Value™: €44.45 vs. price of €58.80 (32.3% above fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score

Get the complete analysis for XMAD:CBAV

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€58.80
Price
€44.45
GF Value